English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Jamie Barrand
| Dec 15, 2015
Ninlaro approved by FDA as multiple myeloma treatment
Jamie Barrand
| Dec 15, 2015
Celiac disease at center of Takeda, Cour research partnership
Jamie Barrand
| Dec 15, 2015
Eliquis shown to be effective treatment for deep vein thrombosis, pulmonary embolism
Jamie Barrand
| Dec 15, 2015
Biogen's ALS therapy research shows promise
Kim Sunderland
| Dec 14, 2015
Criticism mounts as Maine's Obamacare-funded co-op ceases individual enrollment
Kerry Goff
| Dec 14, 2015
Obamacare expense drives closure of popular Nashville restaurant
Kerry Goff
| Dec 14, 2015
U.S. Justice Department expert discusses how insurance mergers could hurt consumer premiums
Jamie Barrand
| Dec 12, 2015
Ibrance may be effective for post-menopausal breast cancer patients
Trending
+
Pharmaceuticals
Patient Daily
| Sep 23, 2025
Wall Street Journal editorial board alleges hospitals misuse 340B program
+
Pharmaceuticals
Patient Daily
| Sep 22, 2025
Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program
+
Pharmaceuticals
Patient Daily
| Sep 22, 2025
Staff Attorney of Legal Aid Society on 340B: 'Hospitals are exploiting the 340B program'
+
Marketing
Patient Daily
| Sep 17, 2025
Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'
« First
«
…
253
254
255
256
257
258
259
…
»
Last »